These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21069943)

  • 1. Searching for biological markers of molecular targeting treatment of liver cancer.
    Arao T; Kudo M; Nishio K
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1879-82. PubMed ID: 21069943
    [No Abstract]   [Full Text] [Related]  

  • 2. [Translational research of molecular targeting drug for liver cancer].
    Tanaka S; Ui S
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1874-7. PubMed ID: 21069942
    [No Abstract]   [Full Text] [Related]  

  • 3. Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?
    Doki Y; Monden M
    J Gastroenterol; 2004 Dec; 39(12):1228-9. PubMed ID: 15622495
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: angiogenesis soluble factors as liver disease markers.
    Salcedo X; Medina J; Sanz-Cameno P; García-Buey L; Martín-Vilchez S; Moreno-Otero R
    Aliment Pharmacol Ther; 2005 Jul; 22(1):23-30. PubMed ID: 15963076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in cancer.
    Juczewska M; Chyczewski L
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():86-100. PubMed ID: 9337527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current problems with systemic treatment of advanced hepatocellular cancer.
    He AR; Soe K; El Zouhairi M
    Curr Probl Cancer; 2010; 34(2):131-49. PubMed ID: 20417353
    [No Abstract]   [Full Text] [Related]  

  • 9. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J; Herbst RS; Onn A
    Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
    Chaplin DJ; Hill SA
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1381-4. PubMed ID: 12498016
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver, pancreas, biliary tract cancer-basic and clinical researches for molecular targeting drug of liver cancer-].
    Ui S
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1872-3. PubMed ID: 21046843
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
    Ianov IuK; Novik AA; Belokhvostov AS
    Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current advances in molecular targeted therapy of primary hepatocellular carcinoma].
    Yu L; Dai Z; Zhou J; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):475-7. PubMed ID: 19567036
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary hepatic neuroendocrine carcinoma: an underdiagnosed entity.
    Dala R; Shoosmith J; Lilenbaum R; Cabello-Inchausti B
    Ann Diagn Pathol; 2006 Feb; 10(1):28-31. PubMed ID: 16414542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular markers having a prognostic or therapeutic value in cancer].
    Brousset P
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
    Le Tourneau C; Vidal L; Siu LL
    Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
    Vibert E; Samuel D
    J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant germ cell tumor of the liver].
    Sasaki M
    Ryoikibetsu Shokogun Shirizu; 1995; (7):310-3. PubMed ID: 8749480
    [No Abstract]   [Full Text] [Related]  

  • 19. Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model.
    Malcontenti-Wilson C; Muralidharan V; Skinner S; Christophi C; Sherris D; O'Brien PE
    Clin Cancer Res; 2001 Apr; 7(4):1052-60. PubMed ID: 11309357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.